Concepedia

Katayoun I. Amiri

KI

Statistics

Publications

10

Citations

671

H-Index

10

Active since

2004

Affiliations

Vanderbilt University(Current)

Vanderbilt University Medical Center

Meharry Medical College

Vanderbilt-Ingram Cancer Center

VA Tennessee Valley Healthcare System

Katayoun I. Amiri is an author at Vanderbilt University specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

2004–2018

10

Publications

10

BMS-345541 Targets Inhibitor of κB Kinase and Induces Apoptosis in Melanoma: Involvement of Nuclear Factor κB and Mitochondria Pathways

Jinming Yang, Katayoun I. Amiri, James R. Burke et al. · Clinical Cancer Research · 2006 · 167 citations · Full text

, , +17

Augmenting Chemosensitivity of Malignant Melanoma Tumors via Proteasome Inhibition

Katayoun I. Amiri, Linda W. Horton, Bonnie LaFleur et al. · Cancer Research · 2004 · 158 citations · Full text

, , +14

Targeting aurora kinases limits tumour growth through DNA damage‐mediated senescence and blockade of NF‐κB impairs this drug‐induced senescence

Yan Liu, Oriana E. Hawkins, Yingjun Su et al. · EMBO Molecular Medicine · 2012 · 97 citations · Full text

, , +17

RAF265 Inhibits the Growth of Advanced Human Melanoma Tumors

Yingjun Su, Anna E. Vilgelm, Mark C. Kelley et al. · Clinical Cancer Research · 2012 · 62 citations · Full text

, , +17

Differential regulation of CXC ligand 1 transcription in melanoma cell lines by poly(ADP-ribose) polymerase-1

Katayoun I. Amiri, Hyo Chol Ha, Mark E. Smulson et al. · Oncogene · 2006 · 48 citations · Full text

, , +14

1–5 of 10